EBITDA Margin (Annual)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

ImmuCell Corporation (ICCC) had EBITDA Margin of 16.04% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$27.64M
Net Income	$-1.04M
Cost of Goods Sold	$16.20M
Gross Profit	$11.45M
Operating Expenses	$25.99M
Operating Income	$1.65M
Non-Operating Income/Expense	$-2.68M
Pre-Tax Income	$-1.03M
Normalized Pre-Tax Income	$-1.03M
Income after Taxes	$-1.04M
Income from Continuous Operations	$-1.04M
Consolidated Net Income/Loss	$-1.04M
Normalized Income after Taxes	$-1.04M
EBIT	$1.65M
EBITDA	$4.43M
Weighted-Average Shares Outstanding (Basic)	9.03M
Weighted-Average Shares Outstanding (Diluted)	9.03M
Earnings per Share (EPS) (Basic)	$-0.12
Earnings per Share (EPS) (Diluted)	$-0.12
Balance Sheet Financials
Current Assets	$16.94M
Property, Plant, and Equipment	$21.07M
Long-Term Assets	$25.59M
Total Assets	$42.53M
Current Liabilities	$3.98M
Long-Term Debt	$7.49M
Long-Term Liabilities	$11.50M
Total Liabilities	$15.48M
Common Equity	$27.06M
Tangible Shareholders Equity	$26.96M
Shareholders Equity	$27.06M
Common Shares Outstanding	9.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.48M
Cash Flow from Investing Activities	$-1.21M
Cash Flow from Financial Activities	$-1.21M
Beginning Cash	$3.76M
End Cash	$3.81M
Increase/Decrease in Cash	$0.05M
Stock-Based Compensation	$0.30M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.26
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.22
Debt to Equity Ratio	0.34
Gross Margin	41.40%
Operating Margin	5.97%
EBIT Margin	5.97%
EBITDA Margin	16.04%
Pre-Tax Profit Margin	-3.72%
Profit Margin	-3.76%
Free Cash Flow	$1.26M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.65
Inventory Turnover	1.75
Receiveable Turnover	8.09
Days Sales in Receivables	45.14
Return on Equity	-3.84%
Return on Tangible Equity	-3.86%
Return on Assets	-2.45%
Return on Investments	-3.01%
Book Value Per Share	$2.99
Free Cash Flow per Share	$0.14
Operating Cash Flow per Share	$0.27

Data from Zacks Investment Research, Inc.